Doximity (DOCS) Cost of Revenue (2020 - 2026)

Doximity (DOCS) has 7 years of Cost of Revenue data on file, last reported at $112.7 million in Q1 2026.

• Cost of Revenue for Q1 2026 came in at $112.7 million, up 199.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $230.5 million (up 58.17% YoY), and the FY2026 annual result was $163.6 million, up 12.31% from the prior year.
• Cost of Revenue advanced to $112.7 million in Q1 2026 per DOCS's latest filing, from $42.2 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $112.7 million in Q1 2026 and troughed at $12.2 million in Q4 2023.
• A 5-year average of $33.1 million and a median of $34.4 million in 2024 frame the typical range for Cost of Revenue.
• On a YoY basis, Cost of Revenue climbed as much as 215.76% in 2024 and fell as far as 62.09% in 2024.
• A 5-year view of Cost of Revenue shows it stood at $13.5 million in 2022, then slipped by 9.88% to $12.2 million in 2023, then surged by 215.76% to $38.5 million in 2024, then rose by 9.65% to $42.2 million in 2025, then soared by 167.1% to $112.7 million in 2026.
• Business Quant data shows DOCS's Cost of Revenue at $112.7 million in Q1 2026, $42.2 million in Q4 2025, and $39.2 million in Q3 2025.